← Back to charts
iTIVA Anesthesia icon
APP STORE

iTIVA Anesthesia

ANESTESIARTE CALI SAS · Medical · United States store
NOT IN TOP 100 HERE
View on App Store ↗ Instagram card
Revenue a month, worldwide EST
$400
Likely $133 to $1.2K
▼ 100.0% in 4 days
New ratings
Tracking
Daily counts start building from today
Rating
4.6 of 5
45 ratings in this store
Countries it ranks in
0
was 0 on Oct 17, 2026

Revenue

Estimated from the grossing charts of Oct 24, 2026 in the 53 countries we track, and ratings growth on the App Store.

EST. REVENUE / YEAR · WORLDWIDE
$4.8K
2.0 new ratings a month on average since launch
EST. LIFETIME DOWNLOADS
1.6K to 4.5K
Estimated from ratings count
WHERE ITS USERS ARE · SHARE OF RATINGS
  • Mexico 130 ratings41%
  • Brazil 65 ratings21%
  • United States 45 ratings14%
  • Japan 18 ratings6%
  • Italy 13 ratings4%
  • Spain 12 ratings4%
  • Canada 9 ratings3%
  • Australia 5 ratings2%
HOW SURE ARE WE
Not in any grossing chart, so this comes from ratings growth (2.0 new ratings a month on average since launch): revenue grows with new ratings, more slowly for apps that collect ratings fast. Tested on 418 apps with verified revenue: typically off by about 2 times, and big earners tend to come out low. Countries we don't track (and Google Play in China, which doesn't exist) aren't included, and neither are ads or web payments. Gross revenue before store fees.
RATINGS
45
AVG RATING
4.58
PRICE
Free
AGE
13.5y
LAST UPDATE
2781d ago
VERSION
3.5
SIZE
29 MB
AGE RATING
12+

Last 30 days

From our daily snapshots of every grossing chart.

DAYS IN A GROSSING CHART
5 / 30
COUNTRIES NOW
0 (was 0)
EST. REVENUE A MONTH, DAILY · APP STORE EST
Show daily values
Sep 25, 2026not in a grossing chart
Sep 26, 2026not in a grossing chart
Sep 27, 2026not in a grossing chart
Sep 28, 2026not in a grossing chart
Sep 29, 2026not in a grossing chart
Sep 30, 2026not in a grossing chart
Oct 1, 2026not in a grossing chart
Oct 2, 2026not in a grossing chart
Oct 3, 2026not in a grossing chart
Oct 4, 2026not in a grossing chart
Oct 5, 2026not in a grossing chart
Oct 6, 2026not in a grossing chart
Oct 7, 2026not in a grossing chart
Oct 8, 2026not in a grossing chart
Oct 9, 2026not in a grossing chart
Oct 10, 2026$7.5K a month
Oct 11, 2026not in a grossing chart
Oct 12, 2026not in a grossing chart
Oct 13, 2026not in a grossing chart
Oct 14, 2026not in a grossing chart
Oct 15, 2026not in a grossing chart
Oct 16, 2026not in a grossing chart
Oct 17, 2026not in a grossing chart
Oct 18, 2026not in a grossing chart
Oct 19, 2026not in a grossing chart
Oct 20, 2026not in a grossing chart
Oct 21, 2026not in a grossing chart
Oct 22, 2026not in a grossing chart
Oct 23, 2026not in a grossing chart
Oct 24, 2026not in a grossing chart
The same estimate as the headline, saved every day. Best rank Sep 25, 2026: not ranked. Now: not ranked.

Money and momentum

Measured from the store, not estimated.

WHAT IT CHARGES
1 purchase listed
  • iTiva Pro$9.99
Top in-app purchases as listed on the App Store, in local prices.
REVIEW MOMENTUM
Too few reviews
Fewer than 3 recent written reviews in this country.
RELEASE CADENCE
0 updates in 90 days
  • Typical gap between releases92 days
From the last 17 versions listed on the App Store.
RATING BREAKDOWN
45 ratings
5★87%
4★2%
3★2%
2★0%
1★9%

Apps like this

Same category, earning about as much.

Store screenshots

ScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshot

App Store ads

Apple Search Ads this app ran in the last 90 days, from Apple's public ad repository.

No App Store ads in the EU
None in the last 90 days.

Apple only publishes ads shown in the EU (EU Digital Services Act), with a 7 day delay. An app that advertises only outside the EU shows nothing here.

Growth research

Where this app is buying and earning its users. Each link opens pre filtered.

ASO keywords

Most repeated terms in the listing. Highlighted ones also appear in the title.

adults11kids7itiva6models5drugs4infusion4eleveld4pharmacokinetic models3schemes3intravenous3pharmacokinetic3time2information2based2pharmacokinetics2dyck2schnider2delyle2david2purposes2therefore2application2clinical2concentrations2

What's new in 3.5

- Modify patient data during a running simulation: double tap on anthropometric values - NEW PROPOFOL MODEL: Eleveld 2 / BJA - 2018 - TCI algorithm improved - Corrected minor problem with kataria model

Released Apr 22, 2013. Current version shipped Mar 14, 2019.

Store description

TRY IT FOR FREE, 10 USES WITHOUT TIME RESTRICTIONS! iTIVA is a simulation program that provides information about distribution of drugs based on mathematical models, and it simulate the behavior of a TCI pump (up to 3 drugs at time), obtaining infusion rates to reach and maintain a stable target effect site concentration, those schemes can be implemented in volumetric infusion pumps, and be guided with pharmacokinetics models. So now pharmacokinetics can become an easy topic and understanding what is going on during a infusion of a intravenous drug, too. Pharmacokinetic models iTIVA include 11 drugs and 40 pharmacokinetic models, that are updated continuously: -Remifentanil Adults: Minto
, Eleveld, Kim Kids: Rigby-Jones, Eleveld, Ross -Fentanyl
 Adults: Shafer, Scott
 Kids: Ginsberg, Encinas (Neonates) -Sufentanil
 Adults: Gepts, Bovill
 Kids: Greely -Alfentanil
 Adults: Maitre -Ketamine Adults: Domino, Clements-250 
 Kids: Herd, Elkomy -Procaine Adults: Seifen -Lidocaine
 Adults: Dyck, Schnider -Propofol
 Adults: Schnider, Eleveld, Marsh, Cortinez 
 Kids: Peadfusor, Kataria, Eleveld -Dexmedetomidine 
 Adults: Hannivoort, Dyck, Lin, Venn
 Kids: Potts -Midazolam
 Adults: Albrecht, Greenblatt -Tranexamic
 Adults: Grassin-Delyle Kids: Goobie, Grassun-Delyle iTIVA also calculate the end tidal (Et) for Isoflurane, Sevoflurane and Desflurane for the MAC age, with the use of the Mapleson equation. Created by David Ramirez MD, Cali - Colombia. Universidad de Valle. david@itiva.co • WARNING: iTIVA is not designed to handle intravenous drugs for individual patients. Its use is limited to educational purposes to demonstrate pharmacokinetic principles when performing intravenous anesthesia. Therefore the user assumes all risks from the use of this application for clinical purposes. Infusion schemes are obtained from concentrations based on models published in the medical literature; therefore concentrations achieved from these schemes can vary widely, in the same manner for clinical effects. This application should only be used by people with extensive knowledge in Anesthesiology. We don't collect any information about you, for more info about our privacy policy, refer to http://itiva.co/privacy.html

See this store page in another country

Prices, ranks and reviews are per country. Revenue above is already worldwide.

More from ANESTESIARTE CALI SAS

iTIVA Anesthesia Plus
Medical
342 ratingsAnalyze →